Abstract
A large number of epidemiological studies have identified an association between high serum uric acid (SUA) concentrations and increased cardiovascular risk. However, the significance of this relationship has been difficult to interpret due to the co-existence of other cardiovascular risk factors. The relationship between SUA concentrations and morbidity appears particularly strong in patients with hypertension, and a number of recent studies have found that this relationship persists after adjusting for potential confounders. This paper reviews the potential mechanisms by which SUA might be causally related to cardiovascular disease in patients with hypertension. We critically appraise the evidence in favour of a causal, coincidental or compensatory relationship, and consider the potential outcomes of lowering SUA in patients with hypertension. The potential consequences of high SUA concentrations are discussed and, based on existing evidence, consideration is given to the potential therapeutic value of strategies to lower SUA as a means of cardiovascular risk reduction in patients with hypertension.
Keywords: uric acid, cardiovascular risk, hyperuricaemia, hypertension, thiazide diuretics, lipid-lowering treatment
Current Hypertension Reviews
Title: How Should Serum Uric Acid Concentrations be Interpreted in Patients with Hypertension?
Volume: 1 Issue: 1
Author(s): William S. Waring and Shahana Esmail
Affiliation:
Keywords: uric acid, cardiovascular risk, hyperuricaemia, hypertension, thiazide diuretics, lipid-lowering treatment
Abstract: A large number of epidemiological studies have identified an association between high serum uric acid (SUA) concentrations and increased cardiovascular risk. However, the significance of this relationship has been difficult to interpret due to the co-existence of other cardiovascular risk factors. The relationship between SUA concentrations and morbidity appears particularly strong in patients with hypertension, and a number of recent studies have found that this relationship persists after adjusting for potential confounders. This paper reviews the potential mechanisms by which SUA might be causally related to cardiovascular disease in patients with hypertension. We critically appraise the evidence in favour of a causal, coincidental or compensatory relationship, and consider the potential outcomes of lowering SUA in patients with hypertension. The potential consequences of high SUA concentrations are discussed and, based on existing evidence, consideration is given to the potential therapeutic value of strategies to lower SUA as a means of cardiovascular risk reduction in patients with hypertension.
Export Options
About this article
Cite this article as:
Waring S. William and Esmail Shahana, How Should Serum Uric Acid Concentrations be Interpreted in Patients with Hypertension?, Current Hypertension Reviews 2005; 1 (1) . https://dx.doi.org/10.2174/1573402052952780
DOI https://dx.doi.org/10.2174/1573402052952780 |
Print ISSN 1573-4021 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6506 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Strategies of Functional Foods Promote Sleep in Human Being
Current Signal Transduction Therapy Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol
Current Drug Metabolism Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome
Current Pharmaceutical Design Cinnamic Acid Derivatives in Tuberculosis, Malaria and Cardiovascular Diseases - A Review
Current Organic Chemistry Nitric Oxide and Disorders of the Erythrocyte: Emerging Roles and Therapeutic Targets
Cardiovascular & Hematological Disorders-Drug Targets Risk Profiles in Type 2 Diabetes (Metabolic Syndrome): Integration of IL-10 Polymorphisms and Laboratory Parameters to Identify Vascular Damages Related Complications
Current Pharmaceutical Design The Emergent Cardiovascular Risk Factors and Organ Damage in Arterial Hypertension
Current Hypertension Reviews The Effect of Different Grades of PLGA on Characteristics of Microspheres Encapsulated with Cyclosporine A
Current Drug Delivery Resistin and Oxidative Stress as Markers of Atherosclerosis in Obstructive Sleep Apnea
Current Respiratory Medicine Reviews Patent Selections
Recent Patents on Drug Delivery & Formulation Telomeres and their Role in Aging and Longevity
Current Vascular Pharmacology Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Recent Patents on Anti-Cancer Drug Discovery Recent Development on Anti-Obesity Compounds and their Mechanisms of Action: A Review
Current Medicinal Chemistry Vitamin D Insufficiency and Diabetes Risks
Current Drug Targets Ethiopathogenesis, Diagnosis and Prevention of Vascular Calcification in End Stage Renal Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Essential Hypertension: Translating Pathophysiology into Pharmacogenomics
Current Pharmacogenomics Formulation and In Vitro Evaluation of Solid Lipid Microparticles of Candesartan Cilexetil Floating Tablets
Drug Delivery Letters Achievements and Limitations of Complement Inhibition by Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: The Role of Complement Component 3
Mini-Reviews in Medicinal Chemistry Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery 4-methylamphetamine (4-MA): Chemistry, Pharmacology and Toxicology of a New Potential Recreational Drug
Mini-Reviews in Medicinal Chemistry